Members of the healthcare community must coordinate and continuously optimise their activities to achieve medical progress in prevention and care, including early recognition, diagnosis and treatment of diseases. The German healthcare system is called upon to bring together a large number of stakeholders and decision-makers: in addition to doctors, nurses and other healthcare professions, these groups include key bodies such as state and private health insurance companies, hospitals, pension providers, the Joint Government Committee and patient organisations. Together, they must contribute to the development and testing of new healthcare models. After all, even the best medicine or treatment will not help if it is not administered to patients.
At the DLR Project Management Agency, we have supported the Federal Ministry of Health (BMG) for many years, providing an agency office where key figures and decision-makers can come together. We are in charge of the National Cancer Plan and the ‘Pharmadialog’ programme. Our experts are also in demand to advise on issues regarding structuring departmental research and project funding. Here, we cater to a broad spectrum, starting with drug safety, antibiotic resistance, and substance abuse, to child health, rare diseases and nursing.